Difference between revisions of "Template:Chromalveolate antiparasitics"
Jump to navigation
Jump to search
imported>Scientist2 (Rearrange combinations, removal of CDA, Atovaquone (as Malarone), sulfamethoxypyrazine) |
|||
| Line 62: | Line 62: | ||
| group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitors]]<BR>(antifols) | | group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitors]]<BR>(antifols) | ||
| − | | list1 = ''[[2,4-Diaminopyrimidine]]s'' ([[ | + | | list1 = ''[[2,4-Diaminopyrimidine]]s'' ([[pyrimethamine]]) <BR>''[[biguanide]]s'' ([[proguanil]]<sup>#</sup> • [[chlorproguanil]]) |
| group2 = [[Sulfonamide (medicine)|Sulfonamides]] | | group2 = [[Sulfonamide (medicine)|Sulfonamides]] | ||
| − | | list2 = [[Sulfadoxine]] • | + | | list2 = [[Sulfadoxine]] • sulfamethoxypyrazine |
| − | | group3 = | + | | group3 = Coformulation |
| list3 = Fansidar<sup>#</sup> (pyrimethamine-sulfadoxine) | | list3 = Fansidar<sup>#</sup> (pyrimethamine-sulfadoxine) | ||
| Line 76: | Line 76: | ||
| group4 = Other | | group4 = Other | ||
| − | | list4 = [[Atovaquone]] ( | + | | list4 = [[Atovaquone]] (as Malarone) <BR> [[Tetracycline]] • [[Doxycycline]]<sup>#</sup><BR>Clindamycin |
}} | }} | ||
| Line 90: | Line 90: | ||
| groupstyle = background:PowderBlue; | | groupstyle = background:PowderBlue; | ||
| group3 = Combination therapies <BR>(not co-formulated) | | group3 = Combination therapies <BR>(not co-formulated) | ||
| − | | list3 = | + | | list3 = artesunate/SP • artesunate/mefloquine • <BR>quinine/tetracycline • quinine/clindamycin |
| groupstyle = background:PowderBlue; | | groupstyle = background:PowderBlue; | ||
}} | }} | ||